| 3 | Cancer prevention in patients with human immunodeficiency virus infection显示文摘Cancer is a leading cause of death in patients with human immunodeficiency virus(HIV) infection. With the advent of antiretroviral treatment, the risk of AIDS-defining cancers declined but the ageing of this population resulted in the emergence of other common cancers, particularly lung and hepatocellular cancer. Accordingly, screening programs similar to the general population should be implemented in patients with HIV infection. Vaccination against common oncogenic viruses is also essential. However, rates of cancer screening and vaccination against HPV and HBV are considerably low in this population, highlighting a pressing need to educate patients and healthcare professionals about the importance of cancer preventive measures in these vulnerable patients. | Evripidis Valanikas Konstantinos Dinas Konstantinos Tziomalos | 2018 | World Journal of Clinical Oncology2018，9，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员